Incanthera (AQSE:INC) Total Operating Expense : £1.06 Mil (TTM As of Sep. 2023)

View and export this data going back to 2020. Start your Free Trial

What is Incanthera Total Operating Expense?

Incanthera's Total Operating Expense for the six months ended in Sep. 2023 was £0.62 Mil. Incanthera's Total Operating Expense for the trailing twelve months (TTM) ended in Sep. 2023 was £1.06 Mil.

Incanthera Total Operating Expense Historical Data

The historical data trend for Incanthera's Total Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Incanthera Total Operating Expense Chart

Incanthera Annual Data

Trend

Mar20

Mar21

Mar22

Mar23

Total Operating Expense

1.23

1.02

1.09

0.96

Incanthera Semi-Annual Data
	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23
Total Operating Expense	Get a 7-Day Free Trial			0.58	0.50	0.51	0.45	0.62

Incanthera Total Operating Expense Calculation

Total Operating Expense is the primary recurring expense associated with central operations that are incurred in order to generate sales.

Total Operating Expense for the trailing twelve months (TTM) ended in Sep. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was £1.06 Mil.

Incanthera Total Operating Expense Related Terms

Thank you for viewing the detailed overview of Incanthera's Total Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Incanthera (AQSE:INC) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Incanthera PLC (AQSE:INC) » Definitions » Total Operating Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

76 King Street, Manchester, GBR, M2 4NH

Website

http://www.incanthera.com

Incanthera PLC is a specialist dermatology and oncology company focused on transforming cancer treatment by creating environments in which cancer cannot survive. It identifies and develops solutions to current clinical, commercially relevant unmet needs, utilising a new technology. The company's current products are Sol, EP0015, Equin and Duo-C. The company has one segment, namely the development of pharmaceutical products all within the United Kingdom.

Incanthera (AQSE:INC) Headlines

No Headlines